Marshall Wace
PMVP icon

Marshall Wace’s PMV Pharmaceuticals PMVP Stock Holding History

Marshall Wace’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$538K Sell
434,093
-30,993
-7% -$39.4K ﹤0.01% 2411
2025
Q4 		$581K Sell
465,086
-147,540
-24% -$198K ﹤0.01% 2181
2025
Q3 		$858K Buy
+612,626
New +$848K ﹤0.01% 2009
2025
Q1 		– Sell
-11,014
Closed -$16.6K – 2994
2024
Q4 		$16.6K Sell
11,014
-50,677
-82% -$80.3K ﹤0.01% 2515
2024
Q3 		$91.9K Buy
61,691
+48,791
+378% +$75.4K ﹤0.01% 2383
2024
Q2 		$20.9K Sell
12,900
-118,945
-90% -$215K ﹤0.01% 2470
2024
Q1 		$224K Buy
+131,845
New +$246K ﹤0.01% 2202
2023
Q4 		– Sell
-58,062
Closed -$357K – 2517
2023
Q3 		$357K Buy
+58,062
New +$399K ﹤0.01% 1822
2023
Q2 		– Sell
-33,225
Closed -$158K – 2876
2023
Q1 		$158K Sell
33,225
-32,982
-50% -$232K ﹤0.01% 2438
2022
Q4 		$576K Buy
66,207
+21,000
+46% +$224K ﹤0.01% 2318
2022
Q3 		$538K Buy
+45,207
New +$653K ﹤0.01% 2688
2021
Q4 		– Sell
-12,716
Closed -$379K – 4197
2021
Q3 		$379K Buy
+12,716
New +$406K ﹤0.01% 2540
2021
Q1 		– Sell
-16,193
Closed -$996K – 2778
2020
Q4 		$996K Buy
+16,193
New +$635K 0.01% 1215

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Marshall Wace's PMVP Position: Q1 2026 in Review

Marshall Wace reduced its PMV Pharmaceuticals (PMVP) stake by 6.7% in Q1 2026, selling an estimated $39.4K and leaving 434,093 shares worth $538K. The position accounts for ﹤0.01% of the portfolio, ranked #2411.

Marshall Wace first reported a position in PMVP in Q4 2020 and has held it in 13 quarters since. The position peaked at $996K in Q4 2020. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • Marshall Wace held 434,093 shares of PMV Pharmaceuticals worth $538K as of Q1 2026.
  • Marshall Wace sold 30,993 PMV Pharmaceuticals shares in Q1 2026, an estimated $39.4K.
  • PMV Pharmaceuticals made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2411 holding.
  • Marshall Wace first reported a position in PMV Pharmaceuticals in Q4 2020 and has held it in 13 quarters since.
  • Marshall Wace's PMV Pharmaceuticals position peaked at $996K in Q4 2020.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.